Tumefactive demyelination following treatment for relapsing multiple sclerosis with alemtuzumab. (7th March 2017) - Barton, Joshua; Hardy, Todd A.; Riminton, Sean; Reddel, Stephen W.; Barnett, Yael; Coles, Alasdair; Barnett, Michael H.